Showing 91-100 of 3459 results for "".
Tips and Tricks for Prescribing Biologics for Pediatric Patients
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/tips-and-tricks-for-prescribing-biologics-for-pediatric-patients/54662/Dawn Eichenfield, MD, PhD, discusses key takeaways from the “Pediatric Dermatology 2026” session at Maui Derm Hawaii 2026.Addressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.Dysregulation of Type 2 Immune Pathway
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.Connections for the Future of Dermatology
https://practicaldermatology.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.IL-31’s Role in Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/Raj Chovatiya, MD, PhD, MSCI, FAAD, explains the role of the IL-31 pathway in neuroinflammatory disease such as prurigo nodularis.EBD Insights
https://practicaldermatology.com/conferences/maui-derm-2022/ebd-insights/20049/There are a number of new and reliable energy-based devices available. Michael H. Gold, MD discusses tried-and-true technologies as well as new and innovative devices that offer efficacious options on the market for a variety of dermatologic needs.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.EBDs and the Shape of Things to Come
https://practicaldermatology.com/conferences/asds-2021/ebds-and-the-shape-of-things-to-come/20019/Demand for procedures to tighten and tone continues to grow, and technology continues to evolve to meet patient demands. Michael H. Gold, MD discusses new and emerging energy-based devices that may improve outcomes and the patient experience.Skin Care for All
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-care-for-all/19708/Every patient gets skin care, says Michael Gold, MD, who says that a number of good products are now on the market. He identifies some leading formulations.What Dermatologists Ought to Know About Cyspera®
https://practicaldermatology.com/topics/general-topics/what-dermatologists-ought-to-know-about-cyspera/20103/Cyspera has become a "go-to topical product for pigment," says Michael H. Gold, MD. He describes the Cyspera Intensive System and its benefits for the management of hyperpigmentation. He discusses advancements in the Cyspera formulation that enhance outcomes.